HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)

Clinical trials for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) explained in plain language.

Never miss a new study

Get alerted when new HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) trials appear

Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cell therapy targets tough blood cancers in early trial

Disease control Recruiting now

This study tests an experimental treatment called GT719 for adults with certain blood cancers (B-cell lymphoma or leukemia) that have come back or not responded to standard therapy. The treatment uses specially modified immune cells to target and attack cancer cells that have a p…

Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)

Phase: PHASE1, PHASE2 • Sponsor: Grit Biotechnology • Aim: Disease control

Last updated May 01, 2026 12:14 UTC

HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)

Get alerted when new HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) trials appear

New cell therapy targets tough blood cancers in early trial